FIELD: medicine.
SUBSTANCE: invention refers to medicine, and aims at preventing and treating cachexia. There are used combined beta-adrenergic antagonist and 5-HT1a partial agonists or antagonists selected from the group consisting of (S)-pindolol and (S)-propranolol, or salts thereof.
EFFECT: method enables reducing cachexia-related body weight loss.
15 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| FERMENTED MILK OR VEGETABLE PROTEINS, CONTAINING RECEPTOR LIGAND, AND THEIR APPLICATION | 2005 |
|
RU2403051C2 |
| USE OF BETA BLOCKER FOR PREPARING DRUG FOR TREATING HEMANGIOMAS | 2008 |
|
RU2471500C2 |
| 1,3-DIHYDROIMIDAZOLE-2-THIONE DERIVATIVES AS DOPAMINE-BETA-HYDROXYLASE INHIBITORS | 2008 |
|
RU2501796C2 |
| COMPOSITION FOR TREATING ARTERIAL HYPERTENSION AND CARDIOVASCULAR PATHOLOGIES ASSOCIATED THEREWITH | 2019 |
|
RU2734281C1 |
| USING BETA-BLOCKING AGENT-CONTAINING PHARMACEUTICAL PREPARATION | 2001 |
|
RU2271802C2 |
| NEBIVOLOL-INCLUDING COMPOSITIONS | 2005 |
|
RU2403037C2 |
| AGONISTS OF ALPHA-2B OR 2B/2C ADRENORECEPTORS FOR NEURODEGENERATIVE DISEASES TREATMENT | 2003 |
|
RU2330649C2 |
| NOVEL METHODS | 2008 |
|
RU2484821C2 |
| COMBINATION OF DIPEPTIDILPEPTIDASE IV (DPP IV) INHIBITOR AND CARDIOVASCULAR SUBSTANCE | 2003 |
|
RU2336876C2 |
| PHARMACOLOGICAL COMPOSITION FOR COMPENSATION OF ARTERIAL HYPERTENSION AND ASSOCIATED PATHOLOGIES OF THE CARDIOVASCULAR SYSTEM | 2021 |
|
RU2792884C1 |
